HIV Clinical Trial
Official title:
A Cluster-randomized Controlled Trial of Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission
| Verified date | August 2017 |
| Source | National Center for AIDS/STD Control and Prevention, China CDC |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to evaluate the effectiveness of reducing HIV transmission among sero-discordant couples by applying comprehensive intervention components.
| Status | Completed |
| Enrollment | 11096 |
| Est. completion date | December 31, 2015 |
| Est. primary completion date | December 31, 2015 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 59 Years |
| Eligibility |
Inclusion Criteria: - Couples are required to have a stable relationship and live together in the last 3 months; - Older than 18 years and younger than 60 years; without regard to CD4 count; - Open cohort(any newly diagnosed serodiscordant couples who are eligible for treatment will be included during the study period). Exclusion Criteria: - Couples are not have a stable relationship or do not live together in the last 3 months; - Younger than 18 years old. |
| Country | Name | City | State |
|---|---|---|---|
| China | Center for Disease Control and Prevention, Yunnan Province | Kunming, Dehong, Wenshan, Honghe | Yunnan |
| China | Center for Disease Control and Prevention, Sichuan Province | Liangshan | Sichuan |
| China | Center for Disease Control and Prevention,Guangxi Zhuang Autonomous Region | Nanning, Guilin, Laibin, Qinzhou | Guangxi |
| China | Center for Disease Control and Prevention, Xinjiang Uygur Autonomous Region | Urumchi, Ili | Xinjiang |
| China | Center for Disease Control and Prevention, Henan Province | Zhumadian | Henan |
| Lead Sponsor | Collaborator |
|---|---|
| National Center for AIDS/STD Control and Prevention, China CDC |
China,
Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010 May 15;50 Suppl 3:S85-95. doi: 10.1086/651478. Review. — View Citation
He N, Duan S, Ding Y, Rou K, McGoogan JM, Jia M, Yang Y, Wang J, Montaner JS, Wu Z; China National HIV Prevention Study Group. Antiretroviral therapy reduces HIV transmission in discordant couples in rural Yunnan, China. PLoS One. 2013 Nov 13;8(11):e77981 — View Citation
Stephenson R, Barker J, Cramer R, Hall MA, Karita E, Chomba E, Vwalika C, Allen S. The demographic profile of sero-discordant couples enrolled in clinical research in Rwanda and Zambia. AIDS Care. 2008 Mar;20(3):395-405. doi: 10.1080/09540120701593497. — View Citation
Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, Zhou S, Bulterys M, Zhu H, Chen RY. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet I — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | HIV seroconversion rate of HIV negatives among HIV serodiscordant couples | up to 2 years | ||
| Secondary | Proportion of HIV positives receiving ART among HIV serodiscordant couples | up to 2 years | ||
| Secondary | The incidence rate of AIDS-related diseases of HIV positives among serodiscordant couples | up to 2 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |